Patent · US Active

Assay to determine LRRK2 activity in parkinson's disease

US9187567B2 · kind B2 · utility

4Cited by
7References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 18, 2012
Grant dateNov 17, 2015
Priority date—
Expiry dateMay 18, 2032

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/52
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Disclosed are novel phosphorylation sites identified in LRRK2 and associated with Parkinson's Disease, antibodies that specifically bind to the novel phosphorylation sites, and laboratory and clinical uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.